Pharma Foods International Co.Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharma Foods International Co.Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 2.96 billion Japanese Yen [US$27.05 million]
Panacea Biotec Ltd
(4.51 billion Indian Rupees [US$63.21 million]
of which 80%
was Formulation), and
Hester Pharmaceuticals Limited
based in India
(1.78 billion Indian Rupees [US$24.98 million]
of which 73%
was Poultry Vaccines).
During the year ended July of 2019, sales at
Pharma Foods International Co.Ltd were ¥10.53 billion (US$96.38 million).
increase of 32.6%
versus 2018, when the company's sales were ¥7.94 billion.
This was the fifth consecutive year of sales increases at Pharma Foods International Co.Ltd
(and since 2014, sales have increased a total of 552%).
Sales of Biomedical saw an increase
that was more than double the company's growth rate: sales were up
531.7% in 2019, from
¥36.61 million to ¥231.27 million.